Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Bank of America has cut ABEV to Underperform, and the options market moved in the same direction before the ink was dry.
Why this matters: Three distinct signals converged on Ambev this week. An analyst downgrade, a sharp swing in put-call positioning, and a rising cost to borrow are all pointing the same way, just as the stock sits 12% above where it traded a week ago.
Isabella Simonato at B of A Securities downgraded Ambev from Neutral to Underperform on 7 October, keeping her price target at $3.30. At the current price of $3.22, that target implies only modest upside, and the Underperform rating signals her conviction the stock will lag. It is not an isolated view. Scotiabank cut to Sector Perform in July. UBS has carried a Sell since April. Barclays holds Equal-Weight. The analyst community has been stepping back from Ambev for months.
The put-call ratio rose to 0.44 on 6 October, 2.74 standard deviations above its 20-day mean of 0.32. That is an unusual move. For most of September, the PCR sat locked in a narrow band around 0.31. The jump to 0.46 on 5 October was even sharper, registering 4.4 standard deviations above the mean at the time. Put buyers stepped in hard as the stock rallied 12% over the week. The PCR remains well below its 52-week high of 1.69, so this is not extreme in absolute terms, but the pace of the shift stands out.
The borrow market adds texture. Cost to borrow is 1.51%, up 34% over the past week. That follows a brief spike to 7.65% on 23 September, which has since normalised. Availability stands at 70%, meaning roughly seven shares remain available for every ten already borrowed. That is a moderately tight lending environment. The short score sits at 57.5, and the days-to-cover rank is at the 100th percentile in factor scoring, meaning this stock ranks at the top for the time it would take shorts to unwind relative to typical volume.
Short interest has risen 13% over the past month to around 139 million shares. The float-share percentage is not available in this snapshot, limiting how conclusive that figure is.
Earnings are scheduled for 28 October, 21 days away. The last quarterly print produced a one-day move of just 0.3%, but a five-day drift of minus 2.9%.
See the live data behind this article on ORTEX.
Open ABEV on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
